Fluorescence diagnosis in keratinocytic intraepidermal neoplasias

Journal of the American Academy of Dermatology

Volumn 57, Issue 5, 2007, Pages 824-831

  Smits, Tim ^a   Kleinpenning, Marloes M ^a   Blokx, Willeke A M ^a   van de Kerkhof, Peter C M ^a   van Erp, Piet E J ^a   Gerritsen, Marie Jeanne P ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

KI 67 ANTIGEN; PROTOPORPHYRIN;

ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DIGITAL IMAGING; FLUORESCENCE; HISTOPATHOLOGY; HUMAN; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; KERATINOCYTE; MEASUREMENT; PRECANCER; PRIORITY JOURNAL; SKIN TUMOR; STATISTICAL ANALYSIS; STRATUM CORNEUM;

ADULT; AGED; AGED, 80 AND OVER; AMINOLEVULINIC ACID; CARCINOMA, SQUAMOUS CELL; CELL PROLIFERATION; DIAGNOSIS, COMPUTER-ASSISTED; DIAGNOSIS, DIFFERENTIAL; EPIDERMIS; FEMALE; FLUORESCENCE; HUMANS; IMMUNOHISTOCHEMISTRY; KERATINOCYTES; KI-67 ANTIGEN; MALE; MIDDLE AGED; NEOPLASM STAGING; PHOTOSENSITIZING AGENTS; PROTOPORPHYRINS; SKIN NEOPLASMS;

EID: 35148864521     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2007.06.031     Document Type: Article

References (20)

1. Kennedy J.C., Pottier R.H., and Pross D.C. Photodynamic therapy with endogenous protoporphyrin 9: basic principles and present clinical experience. J Photochem Photobiol B 6 (1990) 143-148
2. Foley P. Clinical efficacy of methyl aminolevulinate (Metvix) photodynamic therapy. J Dermatol Treat 14 Suppl (2003) 15-22
3. Smits T., Robles C.A., van Erp P.E., van de Kerkhof P.C., and Gerritsen M.J. Correlation between macroscopic fluorescence and protoporphyrin IX content in psoriasis and actinic keratosis following application of aminolevulinic acid. J Invest Dermatol 125 (2005) 833-839
4. Andersson-Engels S., Berg, Svanberg K., and Svanberg S. Multi-color fluorescence imaging in connection with photodynamic therapy of delta-amino levulinic acid (ALA) sensitized skin malignancies. Bioimaging 3 (1995) 134-143
5. Ericson M.B., Sandberg C., Gudmundson F., Rosen A., Larko O., and Wennberg A.M. Fluorescence contrast and threshold limit: implications for photodynamic diagnosis of basal cell carcinoma. J Photochem Photobiol B 69 (2003) 121-127
6. Martin A., Tope W.D., Grevelink J.M., Starr J.C., Fewkes J.L., Flotte T.J., et al. Lack of selectivity of protoporphyrin-Ix fluorescence for basal-cell carcinoma after topical application of 5-aminolevulinic acid-implications for photodynamic treatment. Arch Dermatol Res 287 (1995) 665-674
7. Peng Q., Soler A.M., Warloe T., Nesland J.M., and Giercksky K.E. Selective distribution of porphyrins in skin thick basal cell carcinoma after topical application of methyl 5-aminolevulinate. J Photochem Photobiol B 62 (2001) 140-145
8. Stenquist B., Ericson M.B., Strandeberg C., Molne L., Rosen A., Larko O., et al. Bispectral fluorescence imaging of aggressive basal cell carcinoma combined with histopathological mapping: a preliminary study indicating a possible adjunct to Mohs micrographic surgery. Br J Dermatol 154 (2006) 305-309
9. Stefanidou M., Tosca A., Themelis G., Vazgiouraki E., and Balas C. In vivo fluorescence kinetics and photodynamic therapy efficacy of delta-aminolevulinic acid-induced porphyrins in basal cell carcinomas and actinic keratoses; implications for optimization of photodynamic therapy. Eur J Dermatol 10 (2000) 351-356
10. Angell-Petersen E., Sorensen R., Warloe T., Soler A.M., Moan J., Peng Q., et al. Porphyrin formation in actinic keratosis and basal cell carcinoma after topical application of methyl 5-aminolevulinate. J Invest Dermatol 126 (2006) 265-271
11. Yantsos V.A., Conrad N., Zabawski E., and Cockerell C.J. Incipient intraepidermal cutaneous squamous cell carcinoma: a proposal for reclassifying and grading solar (actinic) keratoses. Semin Cutan Med Surg 18 (1999) 3-14
12. Kleinpenning M.M., Smits T., Ewalds E., van Erp P.E.J., van de Kerkhof P.C.M., and Gerritsen M.J.P. Heterogeneity of fluorescence in psoriasis after application of 5-aminolevulinic acid: an immunohistochemical study. Br J Dermatol 155 (2006) 539-545
13. Keating J.T., Cviko A., Riethdorf S., Riethdorf L., Quade B.J., Sun D., et al. Ki-67, cyclin E, and p16INK4 are complimentary surrogate biomarkers for human papilloma virus-related cervical neoplasia. Am J Surg Pathol 25 (2001) 884-891
14. Rijzewijk J.J., van Erp P.E., and Bauer F.W. Two binding sites for Ki67 related to quiescent and cycling cells in human epidermis. Acta Derm Venereol 69 (1989) 512-515
15. Moan J., Ma L.W., and Iani V. On the pharmacokinetics of topically applied 5-aminolevulinic acid and two of its esters. Int J Cancer 92 (2001) 139-143
16. Gibson S.L., Cupriks D.J., Havens J.J., Nguyen M.L., and Hilf R. A regulatory role for porphobilinogen deaminase (PBGD) in delta-aminolevulinic acid (delta-ALA)-induced photosensitization?. Br J Cancer 77 (1998) 235-243
17. Krieg R.C., Messmann H., Rauch J., Seeger S., and Knuechel R. Metabolic characterization of tumor cell-specific protoporphyrin IX accumulation after exposure to 5-aminolevulinic acid in human colonic cells. Photochem Photobiol 76 (2002) 518-525
18. Ibbotson S.H., Jong C., Lesar A., Ferguson J.S., Padgett M., O'Dwyer M., et al. Characteristics of 5-aminolevulinic acid-induced protoporphyrin IX fluorescence in human skin in vivo. Photodermatol Photoimmunol Photomed 22 (2006) 105-110
19. Moan J., Bech O., Gaullier J.M., Stokke T., Steen H.B., Ma L.W., et al. Protoporphyrin IX accumulation in cells treated with 5-aminolevulinic acid: dependence on cell density, cell size and cell cycle. Int J Cancer 75 (1998) 134-139
20. Fukuda H., Batlle A.M., and Riley P.A. Kinetics of porphyrin accumulation in cultured epithelial cells exposed to ALA. Int J Biochem 25 (1993) 1407-1410